Thomas A. Raffin, Director at Akoya Biosciences, Inc. (AKYA), bought 2,020,000 shares at $5.00 ($10.1M) on 2023-06-12, disclosed to the SEC on 2023-06-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 20,000 | $100K | 1.0% |
| 2 | $5.00 | 196,627 | $983K | 9.7% |
| 3 | $5.00 | 1,803,373 | $9.0M | 89.3% |
| Total | $5.00 avg | 2,020,000 | $10.1M | 100% |
| Filing → |
| LDRH | SELL | 2015-02-23 | $8.5M | — | Filing → |
| LDRH | SELL | 2014-10-01 | $884K | — | Filing → |
| LDRH | SELL | 2014-09-26 | $6.2M | — | Filing → |